Iowa General Assembly Banner


Text: H01634                            Text: H01636
Text: H01600 - H01699                   Text: H Index
Bills and Amendments: General Index     Bill History: General Index



House Amendment 1635

Amendment Text

PAG LIN
  1  1    Amend House File 715 as follows:
  1  2    #1.  Page 15, by striking lines 21 and 22 and
  1  3 inserting the following:
  1  4    "1.  a.  The department shall continue prospective
  1  5 drug utilization review and may establish drug
  1  6 surveillance prior authorization under the medical
  1  7 assistance program.
  1  8    b.  The department shall develop and implement an
  1  9 individual patient tracking system to assess the
  1 10 effectiveness of the drug prior authorization program.
  1 11 The system shall include patient specific elements
  1 12 including, at a minimum, the drug prescribed or
  1 13 requested, the alternative drug dispensed, the
  1 14 quantity requested, the quantity dispensed, and the
  1 15 drugs dispensed during required trials.
  1 16    c.  The department shall conduct a prior
  1 17 authorization cost-effectiveness study, at no cost to
  1 18 the state, and shall not use any entity or individual
  1 19 currently or previously utilized by the department to
  1 20 perform the study.
  1 21    d.  The prospective drug utilization review and
  1 22 prior authorization cost-effectiveness studies shall
  1 23 include, but are not limited to, all of the following:
  1 24    (1)  The net cost of the substitution of brand name
  1 25 drugs for which alternatives are required, including
  1 26 the drug rebates, if applicable, under the Iowa prior
  1 27 authorization regimen.
  1 28    (2)  The costs attributable to the ambulatory
  1 29 treatment of iatrogenic, unexpected conditions which
  1 30 result when the prescribed drug is not authorized and
  1 31 a substitution is made under the Iowa prior
  1 32 authorization regimen, when it is possible to
  1 33 determine that the conditions resulted from the
  1 34 substitution of the alternative medication for the
  1 35 prescribed medication.
  1 36    (3)  The costs attributable to institutionalization
  1 37 and treatment for iatrogenic, unexpected conditions
  1 38 which result when the prescribed drug is not
  1 39 authorized and a substitution is made under the Iowa
  1 40 prior authorization regimen when it is possible to
  1 41 determine that the condition resulted from the
  1 42 substitution of the alternative medication for the
  1 43 prescribed medication.
  1 44    (4)  The costs of prescribing mandates, such as
  1 45 requiring two failures of generic drug treatment
  1 46 before allowing the prescribing of a brand name
  1 47 alternative.
  1 48    (5)  The measurement of the cost-effectiveness of
  1 49 patient outcomes under prior authorization compared to
  1 50 the patient outcomes under prospective drug
  2  1 utilization review.
  2  2    (6)  The comparison of administrative costs for
  2  3 prior authorization review and prospective drug
  2  4 utilization review.
  2  5    The department shall review the methodology for
  2  6 calculating and projecting costs savings and shall
  2  7 update the methodology, if necessary.
  2  8    The costs identified under the studies performed
  2  9 shall be netted against the cost savings projected by
  2 10 the department to accurately determine and report cost
  2 11 savings for the drug prior authorization program.
  2 12    The department shall submit a report of the studies
  2 13 to the general assembly on or before March 1, 1998,
  2 14 for review.  Subsequent to that date, the general
  2 15 assembly may direct the department to remove from the
  2 16 categories of prescription drugs for which prior
  2 17 authorization is currently required, all of the drugs
  2 18 for which the comparative studies establish that
  2 19 prospective drug utilization review is at least as
  2 20 cost-effective in patient outcomes as prior
  2 21 authorization." 
  2 22 
  2 23 
  2 24                               
  2 25 HANSEN of Pottawattamie 
  2 26 
  2 27 
  2 28                               
  2 29 HOUSER of Pottawattamie 
  2 30 
  2 31 
  2 32                               
  2 33 BLODGETT of Cerro Gordo 
  2 34 HF 715.512 77
  2 35 pf/jw/28
     

Text: H01634                            Text: H01636
Text: H01600 - H01699                   Text: H Index
Bills and Amendments: General Index     Bill History: General Index

Return To Home Iowa General Assembly

index Search: House Bills and Amendments (77th General Assembly)

© 1997 Cornell College and League of Women Voters of Iowa


Comments about this site or page? webmaster@legis.iowa.gov. Please remember that the person listed above does not vote on bills. Direct all comments concerning legislation to State Legislators.

Last update: Wed Apr 9 03:43:12 CDT 1997
URL: /DOCS/GA/77GA/Legislation/H/01600/H01635/970408.html
jhf